SupplyChainBrain – With the pandemic loosening its grip on drug development, it’s time to consider the longer-term effects that COVID-19 will have on how clinical trials and supporting supply chains adapt to industry’s “new normal.” To maintain a competitive advantage, embracing speed and precision in clinical trial operations will be key to success. One opportunity can be found in just-in-time manufacturing (JTM). …
Read more at: SupplyChainBrain